Intuitive Surgical, Inc.
Intuitive Surgical Announces CEO Transition with Dave Rosa Promotion
Summary
Intuitive Surgical announced on May 14, 2025, that President Dave Rosa will be promoted to Chief Executive Officer, effective July 1, 2025. Current CEO Gary Guthart will transition to Executive Chair of the Board and continue as a director. The Board also appointed Craig Barratt as the lead independent director, effective the same date. Dave Rosa's promotion comes after 29 years with the company, during which he has held various leadership roles, and has been President since May 2023. Gary Guthart, who has been CEO for 15 years, will remain with the company in a senior advisory capacity. Rosa's base salary and bonus opportunity will be increased, and he will receive stock grants. The company issued a press release on May 15, 2025, to announce these changes.
Profitelligence Alerts
Get alerts for ISRG
Be first to know when Intuitive Surgical, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Official SEC Documents
Advertisement